Department of Informatics and Systems, University of Murcia, Facultad de Informatica, Campus de Espinardo, 30100 Murcia, Spain.
Department of Information and Communications Engineering, University of Murcia, Facultad de Informatica, Campus de Espinardo, 30100 Murcia, Spain.
J Biomed Inform. 2018 Aug;84:114-122. doi: 10.1016/j.jbi.2018.07.003. Epub 2018 Jul 5.
Local cumulative antibiograms are useful tools with which to select appropriate empiric or directed therapies when treating infectious diseases at a hospital. However, data represented in traditional antibiograms are static, incomplete and not well adapted to decision-making.
We propose a decision support method for empiric antibiotic therapy based on the Number Needed to Fail (NNF) measure. NNF indicates the number of patients that would need to be treated with a specific antibiotic for one to be inadequately treated. We define two new measures, Accumulated Efficacy and Weighted Accumulated Efficacy in order to determine the efficacy of an antibiotic. We carried out two experiments: the first during which there was a suspicion of infection and the patient had empiric therapy, and the second by considering patients with confirmed infection and directed therapy. The study was performed with 15,799 cultures with 356,404 susceptibility tests carried out over a four-year period.
The most efficient empiric antibiotics are Linezolid and Vancomycin for blood samples and Imipenem and Meropenem for urine samples. In both experiments, the efficacies of recommended antibiotics are all significantly greater than the efficacies of the antibiotics actually administered (P < 0.001). The highest efficacy is obtained when considering 2 years of antibiogram data and 80% of the cumulated prevalence of microorganisms.
This extensive study on real empiric therapies shows that the proposed method is a valuable alternative to traditional antibiograms as regards developing clinical decision support systems for antimicrobial stewardship.
在医院治疗传染病时,局部累积药敏谱是一种有用的工具,可用于选择合适的经验性或靶向治疗。然而,传统药敏谱中呈现的数据是静态的、不完整的,并且不太适合决策。
我们提出了一种基于需要治疗失败数(NNF)的经验性抗生素治疗决策支持方法。NNF 表示需要用特定抗生素治疗的患者数量,以使一个人治疗不足。我们定义了两个新的指标,累积疗效和加权累积疗效,以确定抗生素的疗效。我们进行了两项实验:第一项是在怀疑感染且患者接受经验性治疗时进行的,第二项是在考虑确诊感染和靶向治疗的患者时进行的。该研究使用了 15799 份培养物,在四年期间进行了 356404 次药敏试验。
血液样本中最有效的经验性抗生素是利奈唑胺和万古霉素,尿液样本中最有效的经验性抗生素是亚胺培南和美罗培南。在这两项实验中,推荐的抗生素的疗效均显著大于实际使用的抗生素的疗效(P < 0.001)。当考虑 2 年的药敏谱数据和 80%的微生物累积流行率时,可获得最高的疗效。
这项关于真实经验性治疗的广泛研究表明,与传统药敏谱相比,所提出的方法是开发抗菌药物管理临床决策支持系统的一种有价值的替代方法。